Publications by authors named "Song-feng Xu"

Beta-tricalcium phosphate (-TCP) refers to one ideal bone repair substance with good biocompatibility and osteogenicity. A digital light processing (DLP)-system used in this study creates bioceramic green part by stacking up layers of photocurable tricalcium phosphate-filled slurry with various -TCP weight fractions. Results show that the sintering shrinkage is anisotropic and the shrinkage vertically reaches over that horizontally.

View Article and Find Full Text PDF

Background: The aim of this study was to evaluate the landscape of gene mutations and the clinical significance of tumor mutation burden (TMB) in patients with soft tissue sarcoma who underwent surgical resection and received conventional adjuvant therapy.

Methods: A total of 68 patients with soft tissue sarcoma were included. Postoperative tumor tissue specimens from the patients were collected for DNA extraction.

View Article and Find Full Text PDF

A wide resection of the tumor with or without chemotherapy is the treatment of choice for periosteal osteosarcoma (PO) of the extremities, however, post-operative limb function and quality of life could be compromised. The present study reports two cases of 14-year-old boys who presented with progressively enlarging masses in their right knee regions. Computed tomography and magnetic resonance imaging scans indicated a fusiform space-occupying mass encircling the bone cortex, with stippled calcification.

View Article and Find Full Text PDF

Objectives: To demonstrate the functional results and emotional acceptance after scapulectomy for various malignant shoulder tumors.

Methods: Eight patients with malignant shoulder tumors who had undergone scapulectomy between April 2004 and March 2014 were retrospectively reviewed. They comprised seven men and one woman their mean age was 54 years (range, 24-69 years).

View Article and Find Full Text PDF

Objective: To study the impacts of tumor location, nature and extent of bone destruction on selection of operative protocol for extremity osteosarcoma (OS).

Methods: The medical records of 201 patients with extremity OS treated in our institute from December 1999 to June 2014 were retrospectively reviewed. Ninety eligible patients (56 males and 34 females) of average age 20 ± 11 years (range, 4-40 years) were enrolled.

View Article and Find Full Text PDF

Major wound complications of the extremities, following wide tumor resection and reconstruction for soft-tissue sarcomas (STSs), remain a challenge for limb-sparing surgery. Furthermore, STSs with ulceration or impending ulceration predispose patients to an increased risk of post-operative infection. The present study was conducted to assess the efficacy of negative pressure wound therapy (NPWT) in preventing wound complications associated with surgical treatment of STSs with ulceration or impending ulceration, in patients treated between February 2012 and January 2013.

View Article and Find Full Text PDF

Giant cell tumor of the tendon sheath (GCTTS), also termed tendosynovial giant cell tumor, is a benign, slow-growing tumor that originates from the tendon sheath or bursa. GCTTS of the foot and ankle is much less frequently reported compared with GCTTS of the hand and knee. However, GCTTS should be considered as a differential diagnosis of soft tissue tumors of the foot and ankle.

View Article and Find Full Text PDF

There is controversy regarding the impact of infection on long-term prognosis in osteosarcoma patients. Clinical trials and experiments relating to this field could bring reconsideration of immunotherapy for osteosarcoma. The clinical records were reviewed of 125 osteosarcoma patients with a mean follow-up of 5.

View Article and Find Full Text PDF
Article Synopsis
  • This review looks at studies about pelvic giant cell tumors (GCTs) to understand things like how often they come back and the problems caused by treatments.
  • After searching through many articles, they found 38 studies with data on 165 patients from 1949 to 2012.
  • The findings showed that most patients were around 33 years old, had GCTs mostly in the hip area, and while many faced complications after treatment, only a few sadly passed away.
View Article and Find Full Text PDF

Background: The combination of chemotherapeutic drugs with different pharmacological action has emerged as a promising therapeutic strategy in the treatment of cancers. Present study examines the antitumor potential of paclitaxel (PTX) and etoposide (ETP)-loaded PLGA nanoparticles for the treatment of osteosarcoma.

Results: The resulting drug-loaded PLGA NP exhibited a nanosize dimension with uniform spherical morphology.

View Article and Find Full Text PDF

Background: We tried to compare the functional and psychosocial outcomes after various reconstruction methods according to tumor location following resection of osteosarcoma in distal femur.

Methods: We retrospectively reviewed 51 patients who underwent limb-salvage surgery of osteosarcoma in distal femur in our institution, 30 males and 21 females with an average age of 21 years (range 13-51 years). We classified osteosarcoma in distal femur into 3 types, and organized affected limb reconstruction methods after wide resection.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers looked at 50 patients with osteosarcoma who got chemotherapy before surgery to see how well they did long-term.
  • After about 5.5 years, 61.7% of the patients were still alive and 57.7% didn’t have any new problems.
  • The study found that a type of surgery called marginal resection is safe and helpful for patients who responded well to chemotherapy.
View Article and Find Full Text PDF
Article Synopsis
  • * Patients: Ten individuals (mostly young adults) were treated, and all of them healed after the first part of the surgery. They were followed for about 34 months.
  • * Results: While some patients had complications and a few died due to the disease, others showed good recovery. Overall, the treatment seemed promising but more research is needed to confirm its safety and effectiveness.
View Article and Find Full Text PDF
Article Synopsis
  • Giant cell tumors (GCT) around the knee can be tricky to treat, especially the more serious grade III type, which makes surgery and recovery important.
  • In a study with eight patients aged 20 to 43, doctors used a special method called alcohol inactivated autograft-prosthesis composite to help repair the knee after removing the tumor.
  • After about 54 months of follow-up, none of the patients had any return of the cancer, and they regained good function in their legs, showing that this technique works well for treating grade III GCT.
View Article and Find Full Text PDF

Background: Giant cell tumor of the sacrum, especially involving the sacroiliac joint, is rare, but is particularly challenging to treat. The long term outcome of a patient was studied with giant cell tumor involving the sacroiliac joint treated with selective arterial embolization and curretage.

Method: One patient with giant cell tumor involving the sacroiliac joint was treated with selective arterial embolization and curettage in our hospital in October 2002.

View Article and Find Full Text PDF

Objectives: To study the long-term outcomes of inactivated bone reimplantation with preservation of the epiphysis in children with distal femoral osteosarcomas.

Methods: Over 10 years, five children (mean age 9.2 years, one boy and four girls) with distal femoral osteosarcomas underwent inactivated bone reimplantation with preservation of the epiphysis following chemotherapy in our hospital.

View Article and Find Full Text PDF
Article Synopsis
  • The study looked at 38 young patients (17 years old on average) with a type of bone cancer called osteosarcoma who underwent surgery after receiving chemotherapy.
  • They found that only one out of the 38 had a local return of cancer, and a few developed spread to the lungs, but overall, many did well after treatment.
  • The researchers concluded that with proper planning and skilled surgeons, surgery could be very effective for treating osteosarcoma.
View Article and Find Full Text PDF

One unsolved problem in bone tissue engineering is how to enable the survival and proliferation of osteoblastic cells in large scaffolds. In this work, large beta-tricalcium phosphate scaffolds with tightly controlled channel architectures were fabricated and a custom-designed perfusion bioreactor was developed. Human fetal bone cells in third passage were seeded onto the scaffolds and cultured in static or flow perfusion conditions for up to 16 days.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the potential of culturing osteoblasts on calcium phosphate cement (CPC) scaffolds with specially designed internal channels using a rotating bioreactor to enhance bone tissue engineering.
  • Osteoblasts were isolated from rabbits and cultured for up to 21 days, during which their growth and differentiation were monitored using various assays, showing better results in rotating conditions compared to static ones.
  • Results indicated that the rotating culture improved cell distribution and function, with identified calcium phosphate structures, suggesting this method could enhance in vitro bone tissue engineering.
View Article and Find Full Text PDF